5-(3-Chloro-phenyl)-thiophene-2-carboxylic acid | 893733-15-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: 5-(3-Chloro-phenyl)-thiophene-2-carboxylic acid
• 英文别名: 2-(3-chlorophenyl)-thiophene-5-carboxylic acid；5-(3-Chlorophenyl)thiophene-2-carboxylic acid
• CAS: 893733-15-8
• 化学式: C₁₁H₇ClO₂S
• mdl: MFCD06801921
• 分子量: 238.694
• InChiKey: PHEPUGXCVVHZGS-UHFFFAOYSA-N

物化性质

• 沸点：
  422.8±35.0 °C(Predicted)
• 密度：
  1.415±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  65.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-(3-Chloro-phenyl)-thiophene-2-carboxylic acid 在 草酰氯 作用下， 以 四氢呋喃 为溶剂， 生成
  参考文献：
  名称：

  Discovery of new C3aR ligands. Part 1: Arginine derivatives

  摘要：

  The synthesis and in vitro binding of several new arginine-containing C3aR ligands are reported. DMPK properties and functional activities of selected compounds have been evaluated. One compound is shown to be active in an in vivo model of airway inflammation after aerosol administration. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.04.022
• 作为产物：
  描述：

  5-溴噻吩-2-甲酸甲酯 在 四(三苯基膦)钯 lithium hydroxide 、 sodium carbonate 作用下， 以 四氢呋喃 、 乙二醇二甲醚 为溶剂， 生成 5-(3-Chloro-phenyl)-thiophene-2-carboxylic acid
  参考文献：
  名称：

  Discovery of new C3aR ligands. Part 1: Arginine derivatives

  摘要：

  The synthesis and in vitro binding of several new arginine-containing C3aR ligands are reported. DMPK properties and functional activities of selected compounds have been evaluated. One compound is shown to be active in an in vivo model of airway inflammation after aerosol administration. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.04.022

文献信息

• [EN] ARYL-1,3-AZOLE DERIVATIVES AND METHODS FOR INHIBITING HEPARNASE ACTIVITY<br/>[FR] DERIVES D'ARYL-1,3-AZOLE ET PROCEDES PERMETTANT D'INHIBER L'ACTIVITE DE L'HEPARANASE
  申请人：IMCLONE SYSTEMS INC

  公开号：WO2005030206A1

  公开（公告）日：2005-04-07

  The present invention encompasses heparanase inhibitors, particularly to certain 2-substituted heteroaryl-fused and aryl-fused carbazole derivatives that inhibit heparanase, pharmaceutical compositions that contain the compounds, methods for making the compounds, and methods of treating heparanase-dependent diseases and conditions in mammals by administering a therapeutically effective amount of the compounds to the mammals.

  本发明涵盖了抑制肝素酶的抑制剂，特别是特定的2-取代杂芳基融合和芳基融合的咔唑衍生物，这些衍生物抑制肝素酶，包含这些化合物的药物组合物，制备这些化合物的方法，以及通过向哺乳动物施用这些化合物的治疗有效量来治疗依赖肝素酶的疾病和病况的方法。
• [EN] THIOPHENE -2- CARBOXYLIC ACID - (1H - BENZIMIDAZOL - 2 YL) - AMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE TEC KINASE ITK (INTERLEUKIN -2- INDUCIBLE T CELL KINASE) FOR THE TREATMENT OF INFLAMMATION, IMMUNOLOGICAL AND ALLERGIC DISORDERS<br/>[FR] DERIVES D'ACIDE THIOPHENE-2-CARBOXYLIQUE (1H-BENZIMIDAZOL-2 YL)-AMIDE ET COMPOSES ASSOCIES UTILISES COMME INHIBITEURS DE LA TEC KINASE ITK (KINASE DES LYMPHOCITES INDUCTIBLES PAR L'INTERLEUKINE -2) POUR TRAITER UNE INFLAMMATION ET DES TROUBLES IMMUNOLOGIQUES ET ALLERGIQUES
  申请人：BOEHRINGER INGELHEIM PHARMA

  公开号：WO2005079791A1

  公开（公告）日：2005-09-01

  Disclosed are compounds of formula (I): wherein Ar1, Ar2, R1, R2, R3, R4 and Xa are defined herein. The compounds of the invention inhibit Itk kinase and are therefore useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.

  揭示了式（I）的化合物：其中Ar1、Ar2、R1、R2、R3、R4和Xa在此定义。该发明的化合物抑制Itk激酶，因此对于治疗涉及炎症、免疫紊乱和过敏疾病的疾病和病理状况是有用的。还公开了制备这些化合物的方法以及包含这些化合物的药物组合物。
• Synthesis and Antimicrobial Evaluation of Nitazoxanide-Based Analogues: Identification of Selective and Broad Spectrum Activity
  作者：T. Eric Ballard、Xia Wang、Igor Olekhnovich、Taylor Koerner、Craig Seymour、Joseph Salamoun、Michelle Warthan、Paul S. Hoffman、Timothy L. Macdonald

  DOI：10.1002/cmdc.201000475

  日期：2011.2.7

  library composed of nitazoxanide‐based analogues was synthesized and assayed for increased antibacterial efficacy against the pyruvate–ferredoxin oxidoreductase (PFOR) using microorganisms Helicobacter pylori, Campylobacter jejuni and Clostridium difficile. Derivatives were found to recapitulate and improve activity against these organisms and select analogues were tested for their ability to disrupt

  合成了一个由基于硝唑尼特的类似物组成的文库，并使用微生物幽门螺杆菌、空肠弯曲杆菌和艰难梭菌对丙酮酸-铁氧还蛋白氧化还原酶 (PFOR) 的抗菌功效进行了分析。发现衍生物可以概括并提高针对这些生物的活性，并测试了选择的类似物直接破坏 PFOR 酶的能力。该文库还针对葡萄球菌的活性进行了筛选，并鉴定出能够以低微摩尔最低抑制浓度抑制葡萄球菌和所有 PFOR 生物体的类似物，并且对人类包皮细胞的毒性较低。
• Design, synthesis and evaluation of novel 5-phenylthiophene derivatives as potent fungicidal of Candida albicans and antifungal reagents of fluconazole-resistant fungi
  作者：Wenbo Yin、Yuxin Zhang、Hengxian Cui、Hong Jiang、Lei Liu、Yang Zheng、Tianxiao Wu、Liyu Zhao、Yin Sun、Xin Su、Song Li、Dongmei Zhao、Maosheng Cheng

  DOI：10.1016/j.ejmech.2021.113740

  日期：2021.12

  5-phenylthiophene derivatives with novel structures were designed and synthesized to combat the increasing incidence of susceptible and drug-resistant fungal infections. The antifungal activity of the synthesized compounds was assessed against seven susceptible strains and six fluconazole-resistant strains. It is especially encouraging that compounds 17b and 17f displayed significant antifungal activities against

  设计和合成了一系列具有新结构的 5-苯基噻吩衍生物，以对抗日益增加的易感和耐药真菌感染的发病率。合成化合物的抗真菌活性针对 7 种敏感菌株和 6 种氟康唑耐药菌株进行了评估。特别令人鼓舞的是，化合物17b和17f对所有测试菌株都显示出显着的抗真菌活性。此外，有效的化合物17b和17f可以防止真菌生物膜的形成，并且17f显示出令人满意的杀菌活性。初步的机理研究表明，化合物17f的强效抗真菌活性源于对白色念珠菌CYP51 的抑制。此外，化合物17b和17f对哺乳动物 A549、MCF-7 和 THLE-2 细胞几乎无毒。这些结果强烈表明化合物17b和17f作为新型抗真菌药物很有前景。
• Tec kinase inhibitors
  申请人：Bentzien Martin Joerg

  公开号：US20050209284A1

  公开（公告）日：2005-09-22

  Disclosed are compounds of formula(I): wherein Ar 1 , Ar 2 , R 1 , R 2 , R 3 , R 4 and X a are defined herein. The compounds of the invention inhibit Itk kinase and are therefore useful for treating diseases and pathological conditions involving inflammation, immunological disorders and allergic disorders. Also disclosed are processes for preparing these compounds and to pharmaceutical compositions comprising these compounds.

  本发明公开了式(I)的化合物：其中Ar1、Ar2、R1、R2、R3、R4和Xa的定义如下。本发明的化合物抑制Itk激酶，因此可用于治疗涉及炎症、免疫紊乱和过敏症的疾病和病理条件。本发明还公开了制备这些化合物的方法和包含这些化合物的药物组合物。